CA2461117A1 - Medicament pour la prophylaxie et la therapie de bromhidrose - Google Patents

Medicament pour la prophylaxie et la therapie de bromhidrose Download PDF

Info

Publication number
CA2461117A1
CA2461117A1 CA002461117A CA2461117A CA2461117A1 CA 2461117 A1 CA2461117 A1 CA 2461117A1 CA 002461117 A CA002461117 A CA 002461117A CA 2461117 A CA2461117 A CA 2461117A CA 2461117 A1 CA2461117 A1 CA 2461117A1
Authority
CA
Canada
Prior art keywords
botulinus toxin
body odour
treatment
botulinus
toxin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002461117A
Other languages
English (en)
Other versions
CA2461117C (fr
Inventor
Marc Heckmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2461117A1 publication Critical patent/CA2461117A1/fr
Application granted granted Critical
Publication of CA2461117C publication Critical patent/CA2461117C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A61K38/4893—Botulinum neurotoxin (3.4.24.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne l'utilisation de botulinumtoxine pour la fabrication d'un médicament destiné à la prophylaxie et/ou à la thérapie de bromhidrose, ainsi que pour la fabrication d'un agent cosmétique destiné à atténuer les odeurs corporelles.
CA002461117A 2001-09-21 2002-09-23 Medicament pour la prophylaxie et la therapie de bromhidrose Expired - Lifetime CA2461117C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10146647.1 2001-09-21
DE10146647A DE10146647A1 (de) 2001-09-21 2001-09-21 Arzneimittel zur Prophylaxe und Therapie von Bromhidrosis
PCT/DE2002/003561 WO2003026602A2 (fr) 2001-09-21 2002-09-23 Medicament pour la prophylaxie et la therapie de bromhidrose

Publications (2)

Publication Number Publication Date
CA2461117A1 true CA2461117A1 (fr) 2003-04-03
CA2461117C CA2461117C (fr) 2009-12-08

Family

ID=7699852

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002461117A Expired - Lifetime CA2461117C (fr) 2001-09-21 2002-09-23 Medicament pour la prophylaxie et la therapie de bromhidrose

Country Status (16)

Country Link
US (1) US20050036966A1 (fr)
EP (2) EP1427385B1 (fr)
JP (1) JP4966478B2 (fr)
KR (1) KR100796243B1 (fr)
CN (1) CN1289061C (fr)
AU (1) AU2002349268B2 (fr)
CA (1) CA2461117C (fr)
DE (1) DE10146647A1 (fr)
EA (2) EA011988B1 (fr)
HU (1) HU230398B1 (fr)
IL (2) IL160875A0 (fr)
MX (1) MXPA04002614A (fr)
PL (1) PL209639B1 (fr)
UA (1) UA78718C2 (fr)
WO (1) WO2003026602A2 (fr)
ZA (1) ZA200402123B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030113349A1 (en) 2001-12-18 2003-06-19 Coleman William P. Topically applied clostridium botulinum toxin compositions and treatment methods
US7288259B2 (en) 2002-08-19 2007-10-30 Ira Sanders Treatment of holocrine gland dysfunction with clostridia neurotoxins
EP1599219A1 (fr) * 2003-03-06 2005-11-30 Botulinum Toxin Research Associates, Inc. Traitment de kystes de meibomius et d'orgelets chroniques avec la toxine botulique
US8048423B2 (en) * 2003-12-09 2011-11-01 Allergan, Inc. Botulinum toxin therapy for skin disorders
BRPI0608249A2 (pt) * 2005-03-03 2009-12-08 Revance Therapeutics Inc formulação, método para aplicação tópica e kit para distribuição transdérmica de toxina botulìnica
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
CA2671447A1 (fr) 2006-12-01 2008-06-12 Anterios, Inc. Nanoparticules a entites amphiphiles
BRPI0914630A2 (pt) * 2008-06-26 2019-09-24 Anterios Inc liberação dérmica
US8454975B1 (en) * 2010-01-11 2013-06-04 Elizabeth VanderVeer Method for enhancing skin appearance
EP3541358A1 (fr) 2016-11-21 2019-09-25 Eirion Therapeutics, Inc. Administration transdermique de grands agents
US11191819B2 (en) 2018-08-28 2021-12-07 Ira Sanders Skin therapeutics

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19852981A1 (de) * 1998-11-17 2000-05-18 Martin Schmidt Botulinum-Toxine, deren Derivate, Analoge und molekulare Bruchstücke zur topischen epicutanen Anwendung auch in Zusammenwirken mit hautpenetrationsfördernden Substanzen und Maßnahmen in Zubereitungsformen zur Beeinflussung acetylcholinabhängiger Körperfunktionen
US20020086036A1 (en) * 2000-12-05 2002-07-04 Allergan Sales, Inc. Methods for treating hyperhidrosis
US20030113349A1 (en) * 2001-12-18 2003-06-19 Coleman William P. Topically applied clostridium botulinum toxin compositions and treatment methods

Also Published As

Publication number Publication date
HU230398B1 (hu) 2016-04-28
US20050036966A1 (en) 2005-02-17
DE10146647A1 (de) 2003-04-24
ZA200402123B (en) 2004-10-04
HUP0401913A2 (hu) 2005-01-28
AU2002349268B2 (en) 2007-12-13
IL160875A0 (en) 2004-08-31
EA011988B1 (ru) 2009-06-30
KR100796243B1 (ko) 2008-01-21
EA200601238A1 (ru) 2007-06-29
JP4966478B2 (ja) 2012-07-04
WO2003026602A2 (fr) 2003-04-03
CN1556693A (zh) 2004-12-22
EP2987483A1 (fr) 2016-02-24
JP2005507888A (ja) 2005-03-24
UA78718C2 (en) 2007-04-25
EA008146B1 (ru) 2007-04-27
CA2461117C (fr) 2009-12-08
PL209639B1 (pl) 2011-09-30
EP2987483B1 (fr) 2020-12-02
EP1427385A2 (fr) 2004-06-16
KR20040048895A (ko) 2004-06-10
PL373528A1 (en) 2005-09-05
MXPA04002614A (es) 2005-02-17
WO2003026602A3 (fr) 2003-08-28
HUP0401913A3 (en) 2008-02-28
EA200400436A1 (ru) 2007-02-27
EP1427385B1 (fr) 2015-09-23
CN1289061C (zh) 2006-12-13
IL160875A (en) 2010-11-30

Similar Documents

Publication Publication Date Title
WO2002056912A3 (fr) Methode de traitement du cancer
TNSN04113A1 (en) 3-â-D-RIBOFURANOSYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF
HK1053989A1 (en) Fused pyrrolocarbazoles against inflammation
MXPA03011515A (es) Nuevas composiciones de medicamentos sobre la base de agentes anticolinergicos, corticoesteroides y agentes betamimeticos.
BG108443A (en) Substituted oxazoliidinones for combinational therapy
MXPA03008623A (es) Combinacion farmaceutica para el tratamiento del cancer.
PT801564E (pt) Utilizacao de nebivolol como agente anti-aterogernico
WO2003053383A3 (fr) Utilisation cosmetique d’au moins une hydrophobine pour le traitement des matieres keratiniques
BR0211450A (pt) Método terapêutico
AU2001247968A1 (en) Use of asiatic acid or asiaticoside for treatment of cancer
CA2461117A1 (fr) Medicament pour la prophylaxie et la therapie de bromhidrose
PT1056454E (pt) Utilizacao de compostos macrolido para o tratamento do glaucoma
BG102250A (en) The use of marigold-extracted glycosides for the treatment of psoriasis
MY139368A (en) Novel cyclohexyl sulphones
GB0020504D0 (en) Therapeutic method
BG104179A (en) Phanquinon administration for the treatment of the alzheimer's disease
JP2005507888A5 (fr)
WO1999051256A3 (fr) Utilisation de l-glu-l-trp pour le traitement d'une infection par vih
NO20032406L (no) Anvendelse av 1-fenyl-3-dimetylaminopropanforbindelser for behandling av urininkontinens
AU2003220773A1 (en) Pharmaceuticals comprising shikonins as active constituent
AU1278600A (en) Novel therapeutic application of nicergoline
AU5416994A (en) Composition for controlling dermatomycoses and their agents, as well as transpiration and bodily odours
WO2003045428A3 (fr) Utilisation d'une cellule techniquement modifiee en tant que vaccin pour traiter une tumeur
WO2003011309A3 (fr) Composition pharmaceutique destinee au traitement de l'hypercholesterolemie
AU2001276323A1 (en) Use of n-oleoylethanolamine for treating psoriasis

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20220923